Needham Maintains Buy on RxSight, Lowers Price Target to $11
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $13 to $11.
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $13 to $11.